![M&A and Strategic Deals: Thermo Fisher, BD, and Quest Use M&A to Advance Post-COVID-19 Strategies](https://www.g2intelligence.com/wp-content/uploads/2023/07/August23.LIR_.MandA-iStock-1404269031_1100x800-1080x675.jpg)
M&A and Strategic Deals: Thermo Fisher, BD, and Quest Use M&A to Advance Post-COVID-19 Strategies
Diagnostics companies that invested heavily in COVID-19 products are relying on M&A transactions to restructure and transition.
Diagnostics companies that invested heavily in COVID-19 products are relying on M&A transactions to restructure and transition.
In the first half of this year, US companies have cut the second-highest total of jobs since 2009, according to a recent report.
A new assay uses AI-optimized enzymes to simplify and increase the accuracy of rapid pathogen detection.
Key approvals announced in June represented important steps forward for the lab testing industry.
Though UDT-related enforcement actions predominate, an uncommon vendor-related case was in the mix this month.